Glenmark to launch phase 1 trial in solid tumors for anti-myeloma drug

Glenmark to launch phase 1 trial in solid tumors for anti-myeloma drug "The company intends to file an Investigational New Drug (IND) application for GBR 1342 in solid tumors and initiate a clinical trial in 2019," the company said in a regulatory filing.

from Moneycontrol Business News
Read The Rest:moneycontrol...